Last reviewed · How we verify

NCT07114913

Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome

Recruiting now Last updated 11 August 2025
What this trial tests

trial testing Nerve ultrasound in Carpal Tunnel Syndrome in 80 participants. Currently enrolling.

Timeline
21 June 2025
Primary endpoint
1 January 2026
1 March 2026

Quick facts

Lead sponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment80
Start date21 June 2025
Primary completion1 January 2026
Estimated completion1 March 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Who can join

Adults 18 to 65, any sex, with Carpal Tunnel Syndrome or Central Sensitisation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare central sensitization parameters between carpal tunnel syndrome (CTS) patients with extra median symptom distribution and those with typical, median nerve-related symptoms. Extra median sensory spread, observed in some CTS patients beyond the anatomical boundaries of the median nerve, may reflect central sensitization mechanisms. Using the Central Sensitization Inventory and pressure pain threshold measurements, this study will assess whether extra median symptom patterns are associated with increased central sensitization.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Nerve ultrasound

Trials testing the same drug.

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07114913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing